[ad_1]

Nov 01, 2022, 05:56PM ISTSource: ANI

According to a study, the majority of melanoma-related deaths occur in people who had an early-stage diagnosis of the deadliest kind of skin cancer and later suffered a recurrence that was often not noticed until it had spread or metastasized. A team led by investigators at Massachusetts General Hospital (MGH) recently developed an artificial intelligence-based method to predict which patients are most likely to experience a recurrence and are therefore expected to benefit from aggressive treatment. The method was validated in a study published in npj Precision Oncology. Most patients with early-stage melanoma are treated with surgery to remove cancerous cells, but patients with more advanced cancer often receive immune checkpoint inhibitors, which effectively strengthen the immune response against tumor cells but also carry significant side effects.



[ad_2]

Source link